Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-138,702
Closed -$2.43M 419
2022
Q2
$2.43M Buy
+138,702
New +$2.51M 0.01% 337
2019
Q2
Sell
-18,400
Closed -$252K 598
2019
Q1
$252K Buy
+18,400
New +$254K ﹤0.01% 951
2018
Q2
Sell
-42,023
Closed -$653K 992
2018
Q1
$653K Buy
+42,023
New +$701K ﹤0.01% 711
2017
Q3
Sell
-31,300
Closed -$646K 997
2017
Q2
$646K Buy
+31,300
New +$627K ﹤0.01% 666
2016
Q3
Sell
-21,900
Closed -$408K 813
2016
Q2
$408K Buy
+21,900
New +$417K ﹤0.01% 790
2014
Q2
Sell
-18,400
Closed -$449K 904
2014
Q1
$449K Buy
+18,400
New +$474K 0.01% 677

Other funds holding ADTN

HBK Investments's ADTN Position: Q3 2022 in Review

HBK Investments sold out of Adtran (ADTN) in Q3 2022, closing a stake of 138,702 shares — an estimated $2.43M sold.

HBK Investments first reported a position in ADTN in Q1 2014 and held it in 6 quarters. The position peaked at $2.43M in Q2 2022. 187 funds tracked by Wall St. Rank hold ADTN as of Q3 2022.

  • HBK Investments reported no remaining Adtran position as of Q3 2022 after selling out during the quarter.
  • HBK Investments sold 138,702 Adtran shares in Q3 2022, an estimated $2.43M.
  • HBK Investments first reported a position in Adtran in Q1 2014 and held it in 6 quarters.
  • HBK Investments's Adtran position peaked at $2.43M in Q2 2022.
  • 187 funds tracked by Wall St. Rank held Adtran as of Q3 2022.

Based on HBK Investments's 13F filing for Q3 2022, filed 14 Nov 2022.